RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 17 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,000 | 0.0% | 17,974 | -9.9% | 0.00% | – |
| Q3 2017 | $10,000 | -16.7% | 19,944 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | -84.0% | 19,944 | -78.5% | 0.00% | – |
| Q1 2017 | $75,000 | +13.6% | 92,755 | 0.0% | 0.00% | – |
| Q4 2016 | $66,000 | -59.3% | 92,755 | +4.8% | 0.00% | – |
| Q3 2016 | $162,000 | -31.1% | 88,509 | -9.6% | 0.00% | – |
| Q2 2016 | $235,000 | – | 97,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Intellectus Partners, LLC | 20,000 | $11,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 42,209 | $23,000 | 0.00% |
| Virtu Financial LLC | 25,413 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 17,974 | $10,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 9 | $0 | 0.00% |
| UBS Group AG | 15,341 | $9,000 | 0.00% |
| Advisor Group, Inc. | 196 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 650 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,721 | $7,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2 | $0 | 0.00% |